234 related articles for article (PubMed ID: 23154492)
1. The pathology of ocular cancer.
Eagle RC
Eye (Lond); 2013 Feb; 27(2):128-36. PubMed ID: 23154492
[TBL] [Abstract][Full Text] [Related]
2. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study.
Eagle RC
Arch Pathol Lab Med; 2009 Aug; 133(8):1203-9. PubMed ID: 19653710
[TBL] [Abstract][Full Text] [Related]
3. [Retinoblastoma and retinocytoma (retinoma)].
Metz KA; Westerwick D; Driever F; Schmid KW; Le Guin CHD
Pathologe; 2017 Nov; 38(6):507-514. PubMed ID: 29043448
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
5. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
[TBL] [Abstract][Full Text] [Related]
6. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
[TBL] [Abstract][Full Text] [Related]
7. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
9. Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma.
Vasalaki M; Fabian ID; Reddy MA; Cohen VM; Sagoo MS
Br Med Bull; 2017 Jan; 121(1):107-119. PubMed ID: 28069617
[TBL] [Abstract][Full Text] [Related]
10. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
Singh HP; Wang S; Stachelek K; Lee S; Reid MW; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9391-E9400. PubMed ID: 30213853
[TBL] [Abstract][Full Text] [Related]
11. Cytodiagnostic clues to primary retinoblastoma based on cytologic and histologic correlates of 39 enucleated eyes.
Tajima Y; Nakajima T; Sugano I; Nagao K; Minoda K; Kondo Y
Acta Cytol; 1994; 38(2):151-7. PubMed ID: 8147204
[TBL] [Abstract][Full Text] [Related]
12. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
13. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
[TBL] [Abstract][Full Text] [Related]
14. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
17. [Non-ocular, malignant secondary tumor following spontaneous healing of a retinoblastoma ("retinoma", "retinocytoma")].
Messmer EP; Richter HJ; Höpping W; Havers W; Alberti W
Klin Monbl Augenheilkd; 1987 Oct; 191(4):299-303. PubMed ID: 2826872
[TBL] [Abstract][Full Text] [Related]
18. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
Chong EM; Coffee RE; Chintagumpala M; Hurwitz RL; Hurwitz MY; Chévez-Barrios P
Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529
[TBL] [Abstract][Full Text] [Related]
19. Trabeculectomy in eyes with unsuspected retinoblastoma.
Chawla B; Hada M; Seth R; Sen S; Gupta V; Kashyap S; Narasimhaiah PC
Ophthalmic Genet; 2016 Dec; 37(4):437-440. PubMed ID: 26966836
[TBL] [Abstract][Full Text] [Related]
20. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
Kashyap S; Sethi S; Meel R; Pushker N; Sen S; Bajaj MS; Chandra M; Ghose S
Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]